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A novel 110-bp insertion in a patient with 
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To the Editor, 
Homocysteinuria is an inherited recessive disor-
der  caused  by  cystathionine  beta-synthase  (CBS) 
deficiency that has a wide spectrum of clinical man-
ifestations, including ocular lens dislocation, skeletal 
disproportion,  osteoporosis,  vascular  thrombosis, 
and central nervous system dysfunction [1]. The CBS 
enzyme catalyzes the synthesis of cystathionine from 
homocysteine and serine in the methionine pathway. 
This  results  in  accumulation  of  homocysteine  and 
methionine in plasma, leading to excretion of exces-
sive  urinary  homocysteine.  CBS  deficiency  has  a 
worldwide incidence of 1/344,000 live births (range: 
1/58,000-1/1000 live births) [2].
Human CBS is located in the cytoplasm of cells 
and is composed of 4 identical 63-kDa subunits. The 
CBS gene is located on the long (q) arm of chromo-
some 21 at position 22.3, encodes a protein consist-
ing of 551 amino acids, and has 16 exons [3]. Herein 
we report a patient with homocysteinuria that was a 
carrier of compound heterozygote mutations in the 
CBS gene, 1 of which is novel, and a discussion of the 
clinical and molecular findings.  
A 14-year-old boy was referred to our hospital 
for  evaluation  of  ocular  symptoms  that  began 
approximately 1 year earlier.  He was the first born 
of  non-consanguineous  parents  that  had  lost  1 
fetus.  Family  history  of  neurologic  and  thrombo-
embolic  disease  was  negative.  Pregnancy  and 
delivery were uneventful. The proband had neuro-
motor developmental delay. At the age of 10 years 
he had a clonic seizure of the left side. He had a 
marfanoid  face  and  neurological  examination 
showed left-sided central facial palsy, and mild left 
hemiparesis. Complete blood count results were 
normal. Cranial CT showed an area of low attenu-
ation  in  the  left  frontoparietal  region  consistent 
with  infarction.  Prothrombotic  work-up  results 
were as follows: serum methionine level: 4.7 mg /
dL  (normal:  0.09-0.6  mg/dL);  free  homocysteine 
concentration:  50  mmol/L    (normal:  <12.5 
mmol/L); urine homocysteine concentration: 360 
mmol/L  (normal: 5-15 mmol/L). The patient was 
diagnosed as homocysteinuria, and hydroxy cobal-
amin  injections,  vitamin  B6,  acetyl-salicylic  acid, 
and a low-methionine diet were started and main-
tained. 
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al  lens  subluxation,  bilateral  cataracts,  and  sec-
ondary glaucoma. The patient underwent cataract 
extraction  in  both  eyes  via  phacoemulsification. 
Both eyes were treated with topical anti-glaucoma 
drops. Additionally, the right eye underwent diode 
laser cyclophotocoagulation with normalization of 
intraocular  pressure  without  any  drops  at  the 
1-year  follow-up.  Intraocular  pressure  in  the  left 
eye remained normal with topical anti-glaucoma 
drops. 
Written  consent  was  provided  by  the  patient’s 
parents. Following  DNA extraction, all the exons of 
the CBS gene were screened via sequencing.  Exon 8 
of the CBS gene was amplified using 2 primer sets   
(F:  5’  CTGAACATTTAGGTCATTACC  3’;  R:  5’  TTT 
CACACGTTTTCCCTGC 3’) under standard PCR con-
ditions, with an annealing temperature of 57°C. PCR 
showed  a  598-bp  amplified  product,  which  was 
cleaned using a DNA purification kit (Metis, Turkey). 
Then,  the  sample  was  sequenced  using  a  DNA 
sequencer  (Beckman  Coulter  DNA  sequencer, 
USA). Direct PCR analysis and sequencing showed 
a 110-bp insertion at exon 8 in the CBS gene (Figures 
1 and 2). A novel 110-bp insertion starting at nt 855 up 
to 965 ending with a new amino acid formation was 
determined. In exon 8 the serine amino acid coded 
by TCC was altered to tryptophan (TGG) due to the 
110-bp insertion. Additionally, a missense mutation at 
exon  8  in  the  CBS  gene  was  also  noted,  which 
caused a T-C transition at base pair 833, resulting in 
an amino acid change from isoleucine to threonine 
(Figure  3).  833  T>C  (p.I1278T)  was  previously 
described (HGMD_CM990350).
Discussion 
We described a 14-year-old patient with homo-
cysteinuria due to 2 mutations in the CBS gene in a 
compound  heterozygous  state.  The  novel  110-bp 
insertion mutation at the intron-exon junction of the 
5’  end  of  exon  8  affected  the  splicing  site.  An 
844ins68 polymorphism was previously reported at 
this localization [4]. Previous research has shown 
that 844ins68 insertion in the CBS gene has a het-
erogeneous distribution in human populations. The 
effect  of  844ins68  on  homocysteine  metabolism 
and its thrombotic effect remain speculative. The 
frequency  of  this  polymorphism  is  5.9%  in  the 
Turkish population [5]. The novel 110-bp insertion 
observed  in  the  presented  case  shows  that  this 
region of the CBS gene may be a hot spot for muta-
tions; the observed mutation and the 844ins68 vari-
ant do not overlap. In conclusion, 110-bp insertion 
plays  an  important  role  in  homocysteine-related 
diseases. 
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Figure 1. Agarose Gel Electrophoretic Analysis of the 110-bp Het-
erozygous Insertion at Exon 8 in the CBS Gene. Band 1 is the DNA 
Marker (ØX174 HaeIII, Fermentas), and Bands 2-6 are DNA Samples 
for the Control. Band 7 is The Patient’s PCR
1  2  3  4  5  6  7
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Figure 3. CBS Gene 833 T>C Transition at Exon 8
T G  C A G   A   T   C  A  T   T   G   G   G   G   T   G   G   A 
190 190
Figure 2. Starting Point of the 110-bp Insertion at Exon 8 in the CBS Gene
A A G G GT   T G G G TC TC  T C G C T G A GCC  T
210 220 230
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